Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Nor… (NCT01553552) | Clinical Trial Compass
CompletedNot Applicable
Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal
Senegal99 participantsStarted 2011-10
Plain-language summary
SchistoVAN aims to study the role of schistosomiasis infection in the modulation of the immune response of children to childhood vaccine antigens, as well as the impact of this infection on their nutritional status and their haemoglobinaemia.
Who can participate
Age range
6 Years – 10 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Members of AnoPalAnoVac cohort
* Age: between 6 and 10 years
Exclusion Criteria:
* body temperature \> 38.5 ºC
* malaria episode
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study looked at how schistosomiasis infection affects how well vaccines work in children — if my child has schistosomiasis, could that mean their routine vaccinations haven't worked as effectively as expected, and should we check their immunity?
2The trial also studied anemia and underweight children alongside schistosomiasis — given that these conditions were all being studied together, should my child be tested for all of them at once, since they might be connected?
3Since this was an observational study in northern Senegal that is now completed, are there published results we could look at together that might be relevant to my child's situation and where we live?
4The study included intestinal parasites as a condition alongside schistosomiasis — could my child have more than one type of parasitic infection at the same time, and does that change how treatment should be approached?
5Because this trial is completed and was not testing a new treatment, what does the research tell us about whether treating schistosomiasis early could help protect my child's response to vaccines and support healthier growth?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.